VanEck Associates’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.3M | Buy |
193,111
+11,840
| +7% | +$3.53M | 0.04% | 265 |
|
|
2025
Q4 | $59.8M | Sell |
181,271
-15,539
| -8% | -$5.27M | 0.05% | 223 |
|
|
2025
Q3 | $68M | Buy |
196,810
+6,993
| +4% | +$2.11M | 0.06% | 184 |
|
|
2025
Q2 | $59.2M | Sell |
189,817
-10,951
| -5% | -$4.19M | 0.07% | 187 |
|
|
2025
Q1 | $105M | Buy |
200,768
+3,861
| +2% | +$1.97M | 0.14% | 128 |
|
|
2024
Q4 | $99.6M | Buy |
196,907
+22,059
| +13% | +$12.5M | 0.13% | 132 |
|
|
2024
Q3 | $98.7M | Buy |
174,848
+14,918
| +9% | +$8.44M | 0.12% | 124 |
|
|
2024
Q2 | $81.4M | Buy |
159,930
+5,505
| +4% | +$2.7M | 0.12% | 134 |
|
|
2024
Q1 | $76.4M | Buy |
154,425
+11,197
| +8% | +$5.69M | 0.12% | 132 |
|
|
2023
Q4 | $75.4M | Buy |
143,228
+9,159
| +7% | +$4.88M | 0.14% | 125 |
|
|
2023
Q3 | $67.6M | Buy |
134,069
+6,345
| +5% | +$3.12M | 0.15% | 129 |
|
|
2023
Q2 | $61.4M | Buy |
127,724
+9,911
| +8% | +$4.85M | 0.13% | 135 |
|
|
2023
Q1 | $55.7M | Buy |
117,813
+5,004
| +4% | +$2.41M | 0.13% | 139 |
|
|
2022
Q4 | $59.8M | Buy |
112,809
+1,102
| +1% | +$584K | 0.15% | 137 |
|
|
2022
Q3 | $56.4M | Buy |
111,707
+6,009
| +6% | +$3.16M | 0.17% | 131 |
|
|
2022
Q2 | $54.3M | Buy |
105,698
+888
| +0.8% | +$446K | 0.14% | 144 |
|
|
2022
Q1 | $53.5M | Buy |
104,810
+8,202
| +8% | +$3.96M | 0.11% | 171 |
|
|
2021
Q4 | $48.5M | Sell |
96,608
-3,092
| -3% | -$1.4M | 0.11% | 164 |
|
|
2021
Q3 | $39M | Buy |
99,700
+8,396
| +9% | +$3.48M | 0.1% | 187 |
|
|
2021
Q2 | $36.6M | Buy |
91,304
+12,294
| +16% | +$4.9M | 0.09% | 192 |
|
|
2021
Q1 | $29.4M | Buy |
79,010
+5,322
| +7% | +$1.84M | 0.08% | 186 |
|
|
2020
Q4 | $25.8M | Buy |
73,688
+9,064
| +14% | +$3.04M | 0.08% | 188 |
|
|
2020
Q3 | $20.1M | Buy |
64,624
+66
| +0.1% | +$20.3K | 0.06% | 180 |
|
|
2020
Q2 | $19M | Buy |
64,558
+6,967
| +12% | +$2M | 0.07% | 182 |
|
|
2020
Q1 | $14.4M | Sell |
57,591
-175,016
| -75% | -$48.2M | 0.07% | 170 |
|
|
2019
Q4 | $68.4M | Sell |
232,607
-58,100
| -20% | -$15.2M | 0.26% | 90 |
|
|
2019
Q3 | $63.2M | Buy |
290,707
+149,560
| +106% | +$36.1M | 0.3% | 79 |
|
|
2019
Q2 | $34.4M | Buy |
141,147
+122,293
| +649% | +$29.4M | 0.17% | 129 |
|
|
2019
Q1 | $4.66M | Sell |
18,854
-2,832
| -13% | -$722K | 0.02% | 335 |
|
|
2018
Q4 | $5.4M | Buy |
21,686
+1,973
| +10% | +$521K | 0.03% | 296 |
|
|
2018
Q3 | $5.24M | Buy |
19,713
+1,517
| +8% | +$395K | 0.03% | 312 |
|
|
2018
Q2 | $4.46M | Buy |
+18,196
| New | +$4.37M | 0.02% | 320 |
|
|
2016
Q2 | – | Sell |
-6,307
| Closed | -$813K | – | 888 |
|
|
2016
Q1 | $813K | Buy |
6,307
+1,024
| +19% | +$121K | 0.01% | 477 |
|
|
2015
Q4 | $621K | Buy |
+5,283
| New | +$617K | ﹤0.01% | 444 |
|
Other funds holding UNH
VCM
VPM
VanEck Associates's UNH Position: Q1 2026 in Review
VanEck Associates increased its UnitedHealth (UNH) stake by 6.5% in Q1 2026, buying an estimated $3.53M and bringing the position to 193,111 shares worth $52.3M. The position accounts for 0.04% of the portfolio, ranked #265.
VanEck Associates first reported a position in UNH in Q4 2015 and has held it in 34 quarters since. The position peaked at $105M in Q1 2025. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.
- VanEck Associates held 193,111 shares of UnitedHealth worth $52.3M as of Q1 2026.
- VanEck Associates bought 11,840 UnitedHealth shares in Q1 2026, an estimated $3.53M.
- UnitedHealth made up 0.04% of VanEck Associates's portfolio in Q1 2026, its #265 holding.
- VanEck Associates first reported a position in UnitedHealth in Q4 2015 and has held it in 34 quarters since.
- VanEck Associates's UnitedHealth position peaked at $105M in Q1 2025.
- 3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.